These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8747166

  • 1. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.
    Warpman U, Nordberg A.
    Neuroreport; 1995 Nov 27; 6(17):2419-23. PubMed ID: 8747166
    [Abstract] [Full Text] [Related]

  • 2. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE, Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, Williams M, Arneric SP.
    J Pharmacol Exp Ther; 1998 May 27; 285(2):777-86. PubMed ID: 9580626
    [Abstract] [Full Text] [Related]

  • 3. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography.
    Sihver W, Gillberg PG, Nordberg A.
    Neuroscience; 1998 Aug 27; 85(4):1121-33. PubMed ID: 9681951
    [Abstract] [Full Text] [Related]

  • 4. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS.
    J Pharmacol Exp Ther; 1994 Jul 27; 270(1):310-8. PubMed ID: 7518514
    [Abstract] [Full Text] [Related]

  • 5. Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex.
    Zhang X, Gong ZH, Fasth KJ, Långström B, Nordberg A.
    Neurochem Int; 1998 Jul 27; 32(5-6):435-41. PubMed ID: 9676742
    [Abstract] [Full Text] [Related]

  • 6. Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease.
    Sihver W, Gillberg PG, Svensson AL, Nordberg A.
    Neuroscience; 1999 Jul 27; 94(3):685-96. PubMed ID: 10579560
    [Abstract] [Full Text] [Related]

  • 7. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain.
    Hellström-Lindahl E, Mousavi M, Zhang X, Ravid R, Nordberg A.
    Brain Res Mol Brain Res; 1999 Mar 20; 66(1-2):94-103. PubMed ID: 10095081
    [Abstract] [Full Text] [Related]

  • 8. Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord.
    Hellström-Lindahl E, Gorbounova O, Seiger A, Mousavi M, Nordberg A.
    Brain Res Dev Brain Res; 1998 Jun 15; 108(1-2):147-60. PubMed ID: 9693793
    [Abstract] [Full Text] [Related]

  • 9. Characterization of [3H]ABT-418: a novel cholinergic channel ligand.
    Anderson DJ, Williams M, Pauly JR, Raszkiewicz JL, Campbell JE, Rotert G, Surber B, Thomas SB, Wasicak J, Arneric SP.
    J Pharmacol Exp Ther; 1995 Jun 15; 273(3):1434-41. PubMed ID: 7791118
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P, Sharples CG, Wonnacott S.
    Mol Pharmacol; 1998 May 15; 53(5):950-62. PubMed ID: 9584223
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
    Parker MJ, Beck A, Luetje CW.
    Mol Pharmacol; 1998 Dec 15; 54(6):1132-9. PubMed ID: 9855644
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and structure-activity data of some new epibatidine analogues.
    Seerden JP, Tulp MT, Scheeren HW, Kruse CG.
    Bioorg Med Chem; 1998 Nov 15; 6(11):2103-10. PubMed ID: 9881100
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
    Gopalakrishnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piattoni-Kaplan M, Donnelly-Roberts D, Arneric SP, Sullivan JP.
    J Pharmacol Exp Ther; 1996 Jan 15; 276(1):289-97. PubMed ID: 8558445
    [Abstract] [Full Text] [Related]

  • 17. Epibatidine is a nicotinic analgesic.
    Qian C, Li T, Shen TY, Libertine-Garahan L, Eckman J, Biftu T, Ip S.
    Eur J Pharmacol; 1993 Dec 21; 250(3):R13-4. PubMed ID: 8112391
    [Abstract] [Full Text] [Related]

  • 18. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
    Marks MJ, Whiteaker P, Collins AC.
    Mol Pharmacol; 2006 Sep 21; 70(3):947-59. PubMed ID: 16728647
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C.
    Br J Pharmacol; 2005 Dec 21; 146(8):1096-109. PubMed ID: 16273122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.